Internal Medicine, Hematology & Oncology · Bristol, CT
NPI
1245348929
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
41 Brewster Rd
Bristol, CT, 06010
Phone (860) 585-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
449 services
Medicare patients, 2024
182
Average age 75
Drug cost, 2024
$1.5M
1,569 prescriptions
Company payments, 2025
$148
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jane M Kanowitz was code 99214 (office e&m - established), 295 times for 129 patients. In total Jane M Kanowitz billed 449 services in 13 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 295 | 129 | $72.74 | $21K |
| 99215 Office E&M - Established | Office | 79 | 44 | $114.01 | $9,007 |
| 99213 Office E&M - Established | Office | 35 | 26 | $44.95 | $1,573 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $140.55 | $2,249 |
| 99205 Office E&M - New | Office | 14 | 14 | $148.39 | $2,077 |
By year: 2022 $38K for 431 services; 2023 $58K for 630 services; 2024 $37K for 449 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jane M Kanowitz prescribed most often to Medicare patients was Anastrozole, with 571 prescriptions and refills. In total Jane M Kanowitz wrote 1,569 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 571 | 1,631 | 184 | $9,449 |
| Tamoxifen Citrate Generic | 274 | 797 | 82 | $8,188 |
| Letrozole Generic | 75 | 179 | 24 | $1,726 |
| Verzenio Abemaciclib | 43 | 43 | Under 11 | $631K |
| Xarelto Rivaroxaban | 33 | 43 | Under 11 | $23K |
| Eliquis Apixaban | 32 | 44 | Under 11 | $26K |
| Escitalopram Oxalate Generic | 31 | 61 | Under 11 | $127 |
| Kisqali Ribociclib Succinate | 26 | 28 | Under 11 | $269K |
| Ibandronate Sodium Generic | 26 | 53 | Under 11 | $315 |
| Oxycodone Hcl Generic | 26 | 26 | Under 11 | $688 |
| Oxybutynin Chloride Generic | 22 | 56 | Under 11 | $244 |
| Ibrance Palbociclib | 22 | 22 | Under 11 | $354K |
| Gabapentin Generic | 22 | 30 | Under 11 | $385 |
| Prochlorperazine Maleate Generic | 22 | 22 | 17 | $301 |
| Lorazepam Generic | 21 | 21 | Under 11 | $70.2 |
Brand drugs: - claims; generic drugs: 1,377 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jane M Kanowitz $148 ($148 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $148.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 30 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.